We are live on ! Find out more
NMC

NEA Management Company Portfolio holdings

AUM $1.76B
1-Year Est. Return 223.33%
This Fund
S&P 500
This Quarter Est. Return
+87.18%
1 Year Est. Return
+223.33%
3 Year Est. Return
+769.45%
5 Year Est. Return
+668.45%
10 Year Est. Return
+14,843.34%
AUM
$2.49B
AUM Growth
+$574M
Cap. Flow
-$341M
Cap. Flow %
-13.72%
Top 10 Hldgs %
64.37%
Holding
51
New
1
Increased
2
Reduced
3
Closed
5

Top Buys

Rank Stock Value
1
AKUS
Akouos Inc
AKUS
+$95.8M
2
AVEO
AVEO Pharmaceuticals, Inc.
AVEO
+$9.02M
3
TRVI icon
Trevi Therapeutics
TRVI
+$5.28M

Top Sells

Rank Stock Value
1
RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
+$295M
2
EPZM
Epizyme, Inc
EPZM
+$67.9M
3
MRSN
Mersana Therapeutics
MRSN
+$54.7M
4
ARDX icon
Ardelyx
ARDX
+$17.4M
5
SENS icon
Senseonics Holdings Inc
SENS
+$7.1M

Sector Composition

Rank Sector Weight
1 Healthcare 79.28%
2 Technology 16.03%
3 Consumer Discretionary 2.25%
4 Industrials 0.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ELGX
51
DELISTED
Endologix Inc
ELGX
– –
-249,022
Closed -$172K
1 2
3

Similar funds

NM
NWI Management New York $1.76B AUM 45.08% 1-Year Est. Return
SLF
Sun Life Financial Toronto, Ontario, Canada $1.76B AUM 19.57% 1-Year Est. Return
CGH
Contrarius Group Holdings Hamilton, Bermuda $1.77B AUM 83.15% 1-Year Est. Return
PWP
Principle Wealth Partners Madison, Connecticut $1.75B AUM 21.63% 1-Year Est. Return
CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
GD
Grandfield & Dodd New York $1.77B AUM 23.43% 1-Year Est. Return
DF
DNCA Finance Paris, France $1.75B AUM 38.18% 1-Year Est. Return
HHAM
HITE Hedge Asset Management Braintree, Massachusetts $1.77B AUM 38.67% 1-Year Est. Return

NEA Management Company's Q2 2020 Portfolio in Review

As of Q2 2020, NEA Management Company held 51 positions worth $2.49B, up 30% from $1.91B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

NEA Management Company withdrew a net $341M in Q2 2020, closing 5 positions and reducing 3 holdings. Its most notable exit was Ra Pharmaceuticals, Inc. Common Stock, an estimated $295M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 79% of assets, down from 84% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, NEA Management Company opened a new position in Akouos Inc worth $96.7M.

  • NEA Management Company's largest Q2 2020 buy was Akouos Inc: 4,298,488 shares worth $96.7M.
  • NEA Management Company added most to AVEO Pharmaceuticals, Inc. in Q2 2020, an estimated $9.02M increase.
  • NEA Management Company's biggest Q2 2020 reduction was Mersana Therapeutics, cutting an estimated $54.7M.
  • NEA Management Company fully exited Ra Pharmaceuticals, Inc. Common Stock in Q2 2020, selling an estimated $295M.
  • NEA Management Company's ten largest holdings make up 64% of its $2.49B portfolio in Q2 2020.
  • NEA Management Company opened 1 new position and closed 5 in Q2 2020.
  • NEA Management Company's portfolio value rose 30% quarter-over-quarter to $2.49B.

Based on NEA Management Company's 13F filing for Q2 2020, filed 5 Aug 2020.